Ausgabe 3/2019
Inhalt (8 Artikel)
Myeloproliferative Neoplasms (B Stein, Section Editor)
Next-Generation Sequencing in Myeloproliferative Neoplasms: Is This Indicated in All Patients?
Alain Antoine Mina, Brady Stein
Myeloproliferative Neoplasms (B Stein, Section Editor)
Key Role of Inflammation in Myeloproliferative Neoplasms: Instigator of Disease Initiation, Progression. and Symptoms
Laura F. Mendez Luque, Amanda L. Blackmon, Gajalakshmi Ramanathan, Angela G. Fleischman
Myeloproliferative Neoplasms (B Stein, Section Editor)
Chronic Myelomonocytic Leukemia: 2018 Update to Prognosis and Treatment
Hany Elmariah, Amy E. DeZern
Myeloproliferative Neoplasms (B Stein, Section Editor)
Integrative Approaches to Managing Myeloproliferative Neoplasms: the Role of Nutrition, Exercise, and Psychological Interventions
Prathibha Surapaneni, Robyn M. Scherber
Health Economics (N Khera, Section Editor)
Trends in Clinical Benefits and Costs of Novel Therapeutics in AML: at What Price Does Progress Come?
Jennifer E. Vaughn, Veena Shankaran, Roland B. Walter
Health Economics (N Khera, Section Editor)
Disparities in Survival and Health Outcomes in Childhood Leukemia
Lena E. Winestone, Richard Aplenc
Multiple Myeloma (P Kapoor, Section Editor)
Expert Panel Consensus Statement for Proper Evaluation of First Relapse in Multiple Myeloma
M. Offidani, M. Boccadoro, F. Di Raimondo, M. T. Petrucci, P. Tosi, M. Cavo